Polfa Tarchomin S.A. has long- lasting experience with API manufacturing being in the past one of the
bigger semi-synthetic antibiotic producer in Europe. At preset Polfa Tarchomin S.A. belongs to limited
group of European pharmaceutical manufacturers, which still synthetizing active pharmaceutical
ingredients for its medical products. Polfa Tarchomin S.A. possesses a new facility dedicated for
manufacturing of APIs. The facility possesses three technological lines for the synthesis of various groups of
substances including antibiotics. Aside from synthesis and isolation existing technological installation can
perform micronisation processes.